(3-Substituted benzyl)thiazolidine-2,4-diones as structurally new antihyperglycemic agents

This publication has 15 references indexed in Scilit:

• Diabetes Complications: Why Is Glucose Potentially Toxic?
  Science, 1996
• The synthesis of BRL 49653 - a novel and potent antihyperglycaemic agent
  Bioorganic & Medicinal Chemistry Letters, 1994
• The Effect of Intensive Treatment of Diabetes on the Development and Progression of Long-Term Complications in Insulin-Dependent Diabetes Mellitus
  New England Journal of Medicine, 1993
• Studies on Antidiabetic Agents. X. Synthesis and Biological Activities of Pioglitazone and Related Compounds.
  CHEMICAL & PHARMACEUTICAL BULLETIN, 1991
• Actions of novel antidiabetic agent englitazone in hyperglycemic hyperinsulinemic ob/ob mice
  Diabetes, 1990
• Studies on hindered phenols and analogs. 1. Hypolipidemic and hypoglycemic agents with ability to inhibit lipid peroxidation
  Journal of Medicinal Chemistry, 1989
• Monitoring and controlling the patient with non-insulin-dependent diabetes mellitus
  Metabolism, 1987
• EFFECT OF TWO YEARS OF STRICT METABOLIC CONTROL ON PROGRESSION OF INCIPIENT NEPHROPATHY IN INSULIN-DEPENDENT DIABETES
  The Lancet, 1986
• Effect of near normoglycaemia for two years on progression of early diabetic retinopathy, nephropathy, and neuropathy: the Oslo study.
  BMJ, 1986
• Studies on antidiabetic agents. I. Synthesis of 5-(4-(2-methyl-2-phenylpropoxy)-benzyl)thiazolidine-2,4-dione (AL-321) and related compounds.
  CHEMICAL & PHARMACEUTICAL BULLETIN, 1982